SLU’s Tina Chen Named a St. Louis Business Journal 40 Under 40 for 2024
Tina Chen, M.D., associate dean of simulation and clinical skills at Saint Louis University School of Medicine, was named a St. Louis Business Journal 40 Under 40 for 2024.
Chen develops simulation-based education for medical students. She is also an associate professor of emergency medicine at SLU, where she serves as the director of simulation for SLU’s Emergency Medicine Residency.
Tina Chen, M.D., associate dean of simulation and clinical skills, teaches in the Sim Center on Aug. 19, 2024. Photo by Sarah Conroy.
Her mission is to develop impactful education for the next generation of clinicians in a psychologically safe teaching environment.
“These roles have allowed me broad experience in designing and implementing high-yield simulation curriculum for clinicians at various stages of training, from the first day of medical school to seasoned faculty,” Chen said.
Chen also serves as a physician at the Chinese Clinic, a non-profit, bilingual, interdisciplinary, cross-institution collaboration between SLU and Washington University medical students and pharmacy students at Southern Illinois University. At the monthly clinic, Chen provides health care services for the uninsured and under-insured Chinese immigrants in the greater St. Louis area. Services include primary health screenings, physical exams, and prescription services for those seeking such services.
Chen was born in Houston, Texas, and lived in Taiwan for two years when she was in grade school. She graduated from Washington University School of Medicine and completed her residency from UConn. She then completed a fellowship in medical simulation at the Center of Education, Simulation, and Innovation at Hartford Hospital.
While at SLU, Chen received the Father James McKelvey Tobin Award in 2023, the Golden Apple Clinical Teaching Award in 2022, the Best Teaching Award from the emergency medicine residency, and the Caring Physician Award in 2018.
The St. Louis Business Journal will celebrate the 40 Under 40 honorees at a reception on Nov. 18.
Latest Newslink
- A Camp Friendship that Stirred Up Lifelong BondsIn the summer of 2005, Mary Kate Keenoy (Chaifetz Grad '22) and Genevieve Willman met at SLU's Gardens to Tables culinary camp. What started as a shared interest in cooking grew into a lasting friendship that has endured for two decades.
- Bruce Bacon, M.D.: 1949-2025Bruce Bacon, M.D., professor emeritus of internal medicine, died Sunday, July 6, 2025. He was 75. Bacon was known globally for his expertise in all aspects of clinical hepatology, specifically hemochromatosis, viral hepatitis, chronic liver disease / general hepatology, and liver transplant. Bacon was also a member of the research team that discovered the gene for hemochromatosis, HFE, in 1996.
- SLU Launches William L. Clay, Sr. Institute of Civic Engagement and Economic JusticeThe Clay Institute will provide immersive learning experiences and hands-on training that address the social and economic challenges facing the St. Louis region and the nation. Institute programming will be available to all students with an interest in civic engagement and democratic participation.
- SLU Research Explores Depression's Ripple Effect on DiabetesA study conducted by researchers at Saint Louis University found that patients with depression were more likely to have uncontrolled diabetes over time and that depression contributes to a heightened economic burden to diabetes management.
- SLU/YouGov Poll: Statewide Cell Phone Ban for Missouri Schools Popular with VotersGovernor Mike Kehoe has signed Senate Bill 68 into law, enacting a statewide ban on the use of personal electronic devices, including cell phones, tablets, and smartwatches, throughout the school day in Missouri public and public charter schools.
- SLU Vaccine Center Will Enroll Healthy Volunteers in Yellow Fever Vaccine Clinical TrialSaint Louis University's Center for Vaccine Development will enroll up to 70 adult volunteers in a clinical trial to study the safety elicited by a new investigational vaccine for yellow fever, a potentially deadly disease that is spread by mosquitoes. The research is funded by Sanofi Pasteur.
